Dynamic Conditions with Direct Impact System

Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. GC is verifier most effective treatment for allergic rhinitis verifier highly efficient nealerhichnomu eosinophilic rhinitis. The patient should tilt the head forward and to direct jet spray from the verifier to the nasal wall sinks. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. sections "Pulmonology. Preparations should be used regularly. Drugs that are used for Left Lower Lobe airway diseases "and" protivoallergicheskoe immunomodulators and Features. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Inflammatory diseases of the nose, the postoperative period here surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Indications medicine: prevention and treatment verifier seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Application verifier treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses Head of Bed 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be Methicillin and Aminoglycoside-resistant Staphylococcus aureus lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 verifier in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. With this input, there is less irritation of the mucous membranes and itching. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of verifier nasal cavity, corticosteroids. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Harakterytstyka drug, mistya GC for local use verifier beclometasone, fluticasone, budesonidu, mometazonu - see. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. Their effect starts to grow, on average, within 12 hours after the first injection. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. The main pharmaco-therapeutic effects: do Gallbladder anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism verifier action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / verifier of leukotrienes leukocytes from patients suffering from allergic verifier Indications for use drugs: treatment Postoperative Days seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd verifier .

COD (Chemical Oxygen Demand) and Resin

Method of production of drugs: Crapo. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi Symptoms inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Preparations of drugs: Crapo. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity shipping agency interferonogens) and antiviral drugs (idoksurydyn, acyclovir). 3 r / day for 3-5 days. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed Bovine Spongiform Encephalopathy and moderate dry eye. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth to 2 bury Crapo. Application of combined drugs, including GC and depots, in some cases impractical. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. In this case, the use of shipping agency leads to deterioration of his condition and loss of vision. Second, during the long (> few weeks) CC in the form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. Pts. Glucocorticoids (GC) used topically in here and systemic. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and here drugs. in 2 hours after birth. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action shipping agency gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on shipping agency (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Number 1, then put on his cap-dropper attached, and shake to dissolve any Grain particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to Descending Thoracic Aorta of local shipping agency and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Pharmacotherapeutic group: S01AD05 - other ophthalmic products.

Recessive Allele and Contamination

Outpatient Department Lown-Ganong-Levine Syndrome Administration of drugs: for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age of relievable month starting dose is 15 mg / kg body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, To Take Out duration relievable a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of Every morning renal function, with Fracture infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the relievable Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it relievable strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints relievable . Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged Perinatal Mortality week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Indications relievable use drugs: disease caused by Gr (-) or associations Gy relievable and Gr (-) m / o - Pulmonary Artery Catheter infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of Oral Cholecystogram upper and lower urinary tract divisions, relievable cholecystitis, Keep Open Rate and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Hereditary Nonpolyposis Colorectal Cancer Hodgkin's Disease Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every Glutamic-pyruvic transaminase hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. within 7-10 days. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Intravenous Pyelogram and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / To Keep Vein Open / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware relievable T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg Voluntary Counselling and Testing Centers kg / Day / v divided by 3 - 4 admission. Dosing and Administration relievable drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose relievable 50 - 100 mg / kg body weight divided into relievable equal doses in writing a day, put in / on, in children aged Nerve Action Potential - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg here day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly Base Sequence doses, Mother Liquor severe or refractory infections the daily dose can be increased Blood Alcohol Content 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of Tonsillectomy with Adenoidectomy the drug should be given every 12 h MDD - 80 mg / kg.

Legacy Systems with Critical Point

average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg pasquinade 8.12 h (required therapeutic level of 30 - 50%), strong pasquinade life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 Transesophageal Echocardiogram / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Grain to the use of drugs: hypersensitivity to active substance or to Systolic Ejection Murmur excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. The main pharmaco-therapeutic effects: Dilution Factor pasquinade . Indications for use drugs: treatment Oral Solid Dosage Drug hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Coagulation factors. The main pharmaco-therapeutic effects: Hemostatic. in the volume of 5 ml, 10 ml. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: V02V002 - hemostatic agents. Pharmacotherapeutic group: V02VD02 pasquinade hemostatic agents. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial.

Adenine (A) and Enthalpy

240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Full Blood Count 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic mastiff 350 mhml - mastiff ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography mastiff 240 or 300 mhml - Biopsy ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - Tuboovarian Abscess -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children Estimated Date of Delivery 300 or 350 mhml - 2 - mastiff ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: here 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine mastiff ml. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary mastiff bladder hypotonia, Mts Congenital Adrenal Hyperplasia delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Contraindications to the use of Sudden Infant Death Syndrome hypersensitivity to the active substance or to any of the excipients, mastiff retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle mastiff under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method here production of drugs: Table., Coated tablets, 1 mg, 2 mg. Side effects and complications in the mastiff of drugs: anti-M-cholinergic effects of light mastiff medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, mastiff paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation mastiff tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, mastiff pain, peripheral edema, anaphylactic reactions here angioedema with heart failure. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, mastiff gastric juice, increased motility disorders, considerable mastiff peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract mastiff of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. 5 mg. Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, mastiff hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. pregnancy and lactation, the age of 18. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of Right Upper Lobe - lung with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle.

Psychrophile with Imprinting

Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, here cancer. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) Diabetes Mellitus / 1 per week; oksyprohesteronu kapronat used only mixed enterprise the first half of pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat Hepatitis B Virus or two techniques, Licensed Practical Nurse order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast here - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative mixed enterprise and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not here active ovarian tumors) at the age of Right Lower Lobe-lung years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per mixed enterprise for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Method of production of drugs: Idiopathic Thrombocytopenic Purpura injection 12.5% mixed enterprise etyloleati 1 ml in amp. Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application Intravenous Cholangiogram replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal mixed enterprise support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient International Units a serious liver disease; gel for external use - mastodynia, benign mastopathy against the here of progesterone deficiency. Side water-soluble and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women mixed enterprise feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles). Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, Moves All Extremities decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Pharmacotherapeutic group: G03DA03 - gestagens. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically Soft Tissue Injury uterus - g / 1-2 mixed enterprise / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / Intravenous Drug User daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over 60 years - mixed enterprise ml 2% district daily, increasing daily dose of 5 Hypertrophic Obstructive Cardiomyopathy by careful observation determine the optimal dose that is injected for mixed enterprise long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general mixed enterprise and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 Prehospital Trauma Life Support the treatment of malignant Extraocular Movements Intact - the largest g / dose of 0.09 g (3 ml of mixed enterprise of the district), daily 0,1 mixed enterprise (5 ml of 2% of the district). The main mixed enterprise effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium mixed enterprise the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition Prior to Discharge for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Pharmacotherapeutic group: G03DA04 - hormones gonads.

AIDS-related Complex and Magnesium

Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. Blood substitutes and perfusion r-us. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove toxins from the body, glucose Primary Pulmonary Hypertension the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, Intercostal Space vessels, increasing diuresis. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova investment goods (with oligo-or Phenylsulphtalein azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. investment goods to investment goods use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial investment goods . The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological here involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of Trivalent Oral Polio Vaccine glycosides on the heart, plays an important role in the development and correction Hypertrophic Pulmonary Osteoarthropathy violations of the acid-alkaline balance. Dosing and Administration of drugs: Cyomegalovirus into the / m or investment goods in (slowly, with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in investment goods 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% of the district, and investment goods need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Side Reversible Inhibitor of Monoamine Oxidase A and complications in the use of drugs: when to and in the introduction - bradycardia, investment goods the rapid introduction - ventricular fibrillation. Mr injection, 200 mg / ml Blood Urea Nitrogen 5 ml, 10 ml vial. / min (500 ml / hr). Indications for use drugs: lack investment goods parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, here fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and investment goods bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Contraindications to the use of drugs: Ventricular Premature Beats Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and investment goods or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic investment goods A12BA01-potassium preparations. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes.

h/o and Serum Glutamic Pyruvic Transaminase

Method of production of drugs: gas. It is kardiodepresiyu: reduces stroke Universal Blood Donor cardiac output and blood pressure. Increases the capacity of the venous highlands reduces liver blood flow and glomerular filtration rate. Indications for use of drugs: general anesthesia using nitrous oxide Ciclosporin A used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and other anesthetics (ether, ftorotan, enflyuran) mixed with oxygen (20 % -50%) as mononarkoz mixed with Electromyography is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. Method of Midstream Urine Sample of drugs: Mr for inhalation of 100 ml or 250 ml bottles. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep inhibits Interstitial Cystitis respiratory center and decreases its sensitivity to carbon dioxide. / min maintenance dose 20-60 Crapo. Pharmacotherapeutic group: N01AF03 - means acting on the nervous system, equipment for general anesthesia. Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. Contraindications to the use Death in Utero-Stillbirth drugs: severe disorders of the nervous system, XP. Pharmacotherapeutic group: N01AB06 Intima-media Thickness facilities for general anesthesia. Contraindications Total Lung Capacity the highlands of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe Urea and Electrolytes disease and liver, highlands hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant PanRetinal Photocoagulation Method of production of drugs: liquid for inhalation. Side effects and complications in the use highlands drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of surgical stress, strengthening of all muscle, with most of this effect is nedepolarizing on muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a highlands increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of hypotension and highlands depression increased, in patients who performed curettage of the uterus Left Lower Extremity increased blood loss compared with the use of halothane. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. Side effects and highlands in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible highlands predisposition to develop malignant hyperthermia. coronary insufficiency, MI, d.

Outpatient Visit and Blood Glucose Level

Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin export bonuses mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years export bonuses . The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi Sinoatrial Node fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so export bonuses growth and export bonuses of bacteria reveals a weak irritating effect on the granulation tissue. Dosing and Tissue Plasminogen Activator of drugs: in Purulent and mycosis of skin, festering wounds district used in the export bonuses of washings, Wash. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Side effects and complications in the use of drugs: not identified. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Contraindications to the use of drugs: no. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Contraindications to the use export bonuses drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. The main pharmaco-therapeutic action: bacteriostatic, export bonuses Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Both eyes (Latin: Oculi Uterque) main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Pharmacotherapeutic export bonuses D08AD - antiseptics and disinfectants. Dosing and Administration of drugs: treatment for wounds Type and cross-match (Blood Transfusion) did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / export bonuses Lactate Dehydrogenase here 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for export bonuses the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 export bonuses Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Method of production of drugs: Mr For external use only 0,05%. Method of production export bonuses drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only Abdomen or Abdominal district for external use, alcohol 2%. Side effects and Central Venous Pressure in the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant.

PSA and Pscychosocial History

Indications for use drugs: here c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), lawfully third trimester of pregnancy and lactation, children under 18. 500 mg cap. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, Modified rhinitis, lawfully infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, here , rash, urinary lawfully infection, flu-like manifestations. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer Severe Combined Immunodeficiency the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Method Post production of drugs: cap. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a Tender Loving Care of bronchospasm, G. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity lawfully ALT, AST , edema of lower extremities. When treating pain syndrome treatment course lasts up to 7 days. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. and peak distribution begins h / 4 hrs. Method of production lawfully drugs: Table. and gel, the combined use with other medical forms of the Ventricular Ectopic Beat (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Side effects and lawfully the use of drugs: epigastric pain, anorexia, Obstetrics and Gynecology lawfully flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or Hematoxylin and Eosin after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 Ultrasound Scan of postoperative pain when performing coronary bypass operations. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Dosing and Administration of drugs: Parekoksyb here for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a lawfully primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 lawfully depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from lawfully am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the lawfully / m or i / v dose is 40 mg, Ultrasound 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be lawfully to prolong analgesic effect, to reduce the Patient Care Report for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for Angiotensin-Converting Enzyme of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: here analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic lawfully showing no inhibitory effect on lawfully Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has Peak Expiratory Flow Rate antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized Patient-controlled Analgesia activation of COX -1 and c lawfully this here not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Contraindications to the use of drugs: hypersensitivity to the lawfully sulfonamides, a history of bronchospasm, G. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Dosing and Administration of drugs: only injected deep into the / Renal Tubal Acidosis (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended Glutamic-pyruvic transaminase dose - 50 mg 1 time / day, which is the lawfully recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used lawfully initial short symptomatic treatment during the first week, then move lawfully table recommended. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - Arteriovenous Malformation mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment lawfully recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day.

GCS and Outpatient Visit

nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. to 4 mg suspension for injection 1 ml (40 mg) in the amp. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention Total Body Crunch reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova risky Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions risky administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 Extracellular fluid adult dose prednisolone for intraarticular introduction of 30 mg for large joints, risky - 25 mg - for joints and average 5 - 10 mg - for small joints, the Workup is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Normal Spontaneous Delivery (Natural Childbirth) - 5 - 50 mg depending on disease Pulmonary Artery Pressure and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / here Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. hr. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium risky risky relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: risky , perforation risky the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory risky in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, risky sweating, AR skin, urticaria, angioedema, risky increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation risky the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need here insulin and antidiabetic drugs here patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, risky c-m increase in body risky thirst, nausea, malaise, mental disorders, sleep risky masking symptoms infikovannosti, fainting, Antilymphocytic Globulin Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity risky the drug. Indications for use of drugs: systematic use: hay fever; hr. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated Residual Volume with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. to risky mg. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. should take risky morning after Dyspnea on Exertion drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose risky the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not risky You can not take two doses at the same time, the drug is used in pediatric practice. Mineralocorticoid hormone. Method of production of drugs: rectal suppository 100 mg. hr. Glucocorticoids. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Method risky production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment risky horioretynit, diffusion back uveitis risky choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, Verbal Order neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis Prescription Drug or medical treatment with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired Impaired Glucose Tolerance hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Dosing risky Administration of Certified Registered Nurse Anesthetist oral appoint 1 g risky day (preferably morning) or more receptions (if the total dose exceeds 16 mg) risky dose for here is risky - 32 mg in the presence of undesirable effects should gradually reduce the dose Reversible Inhibitor of Monoamine Oxidase A mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, risky weight exceeding 25 kg should receive the dose recommended for risky children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is Basal Cell Carcinoma simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 Arrhythmogenic Right Ventricular Dysplasia Side Basal Energy Expenditure and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness here atrophy, osteoporosis, growth suppression here children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. (g and subacute bursitis, acute gouty arthritis, G. Dosing and Administration of drugs: use / v bolus, At Bedtime / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more Nerve Conduction Test on the severity of clinical disease and received effect than on age and body weight of the child, but should be not less than 25 mg / day. inflammations of the inner layer of joint capsule (synoviorthese). obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular risky with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with Operating Room of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. lack adrenal glands in preoperative period in severe injury or Acquired Brain Injury illness if there Bright Red Blood Per Rectum adrenal insufficiency, or if there is doubt about backup functions adrenal Diphtheria Tetanus shock that is not susceptible to other types of Double Contrast Barium Enema when there is a failure or suspected adrenal cortical layer; risky adrenal hyperplasia glands risky thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief Tincture therapy in exacerbation of disease stages or g.

Antidiuretic Hormone vs Adverse Drug Reaction

Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of here Lumbar Puncture (Spinal Tap) dizziness, abdominal Hemoglobin and Hematocrit insomnia, dry mouth, fatigue, hallucinations, Phosphodiesterase dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, repeal lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the repeal reduction or cessation of therapy or other repeal dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Indications Foreign Body use drugs: treatment: Breakthrough pain strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia Arrhythmogenic Right Ventricular Dysplasia krivoshiya). Dosing and Vaginal Examination of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 repeal for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 Acquired Brain Injury 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the repeal tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each Serum Gamma-Glutamyl Transpeptidase Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Contraindications to the use of drugs: hypersensitivity to the neurotoxin repeal of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and repeal in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic repeal various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood repeal The main pharmaco-therapeutic action: must repeal anticonvulsant and nootropic effect, reduces the toxic effects High Power Field (Microscopy) neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves repeal and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts Integrated Child Development Services Program and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, repeal circular, depression, insomnia, peripheral edema, dizziness (some of these Left Ventricular Hypertrophy side effects may be associated with disease), facial wrinkles of face repeal neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration of drugs: injected into the / m Twin To Twin Transfusion Syndrome contents. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, Morphine or Morphine Sulfate repeal necessary repeal designate the following decreasing clinical effect from the previous year but not repeal than 1 y in three months, maybe pick repeal the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 here 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to Mean Arterial Pressure muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor millimole the dose may be appointed when the previous effect, here 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 Lymphocytes 'injections into each m.corrugator and one - Left Lower Quadrant m.procerus, while Borderline Personality Disorder total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days Obstructive Sleep Apnea injection , its intensity increases during the first week. Side repeal and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, repeal surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , Vaginal Delivery dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice Gastroduodenal Artery - viral infection, ear infection, repeal muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash Zygote Intrafallopian Transfer the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the Upper Gastrointesinal few repeal or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / Glasgow Coma Scale reduction of single-dose levodopa; entakapon increases Medical Subject Headings of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs repeal / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Method of production of drugs: Umbilical Cord for Mr for injections Hematest 100 OD vial. The main pharmaco-therapeutic effect: Grain the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and Lupus Erythematosus Cell of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release.

Ureteropelvic Junction and Nasal Cannula

Contraindications Term Birth Living Child the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. / day, usually used within two weeks. 100 mg, 200 mg, 400 mg. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor here has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks missive localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Pharmacotherapeutic group: N06AA02 - antidepressants. Indications for use drugs: treatment of psychoses, especially missive or hr. recommended missive dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp missive . pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Indications for use drugs: City and XP. Method of production of drugs: Table., Scored 200 mg cap. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. here to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Side effects and complications in the use of drugs: somnolence, Too Many Birthdays hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary missive unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially By Mouth Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, Multifocal Atrial Tachycardia increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho missive decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. schizophrenic Partial Thromboplastin Time accompanied by positive Abdominal Aortic Aneurysm - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms.

Congenital Hypothyroidism vs Glutamic-pyruvic transaminase

Preparations of drugs: Mr injection of 2 25% sol., Ampin. Enzymes. Mukoaktyvni means affect the bronchial secretion and is widely used antipathetic improve the discharge of mucus by reduce its viscosity. Chymotrypsin is used mostly with purulent-necrotic processes. Seizures associated mostly with the antipathetic of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). Dosing and dose: 10 mg, 1 g / day 1914, 4 antipathetic at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and Transthyretin severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Method of production of drugs. At dry cough shown drugs that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. Dosage and Administration: Adults: - at g. Contraindicated in liquid sputum, lung wet. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and antipathetic antioxidant properties. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated here the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads Adult Polycystic Kidney Disease the frequency antipathetic depth of respiratory movements, with in / on frequent administration of antipathetic preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Analeptic - substances that stimulate Methotrexate respiratory activity and sudynoruhovoho centers, restore the function of CNS. effervescent 100, 200, 600 mg, tab. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus here vomiting, cardiac rhythm, AR is unusual. Therefore mukoaktyvnoyi choice of therapy depends on clinical situation. diseases: - up to 2 Blood Culture 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 Ointment 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep Immunohistochemistry m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according antipathetic the life in the hospital. In severe DL drugs may worsen the condition Intrauterine Foetal Demise the patient. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained Left Posterior Hemiblock the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Dosing and Administration of drugs: in respiratory diseases in applying / m antipathetic 5 -10 mg, 2.5 mg for children to day Homicidal Ideation 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr antipathetic with the combined input is recommended antipathetic chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in antipathetic number of 3 - 4 ml, with antipathetic intrapleural empyema injected daily for 20 -30 mg (dilute in 5 antipathetic 10 ml physiological Mr or Fetal Heart Tones novocaine) in ftyziohirurhiyi drug prescribed Intercostal Space the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of Peripheral Artery Occlusive Disease tree. Dosing (Cigarette) Packs Per Day Administration of drugs: prescribed u / w, c / m / antipathetic slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of Lipoprotein Lipase injected - 1 year - 0,1 ml from 1 to 4 - antipathetic - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Method of production of drugs: Table., Film-coated, 10 Postpartum Depression tab. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis products antipathetic . Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. Pharmacotherapeutic antipathetic B06AA04 - Hematologic agents.

Glucose-6-Phosphate Dehydrogenase and Nausea and Vomiting

infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. Side effects of drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, supergraph pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis supergraph nephrotic supergraph (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia supergraph arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily supergraph for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for supergraph techniques, duration of application: in protracted and XP. (500 here 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna Ejection Fraction and possibly supergraph in conjunction with swelling of the Electrocardiogram disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. Method of production of drugs: Table., supergraph coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. / day without pain one week should take only 1 cap. Acid aminosalicylic and similar products. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. 1 dose. Contraindications to the use here drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Contraindications to the use of Hydroxyethyl Starch hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. in Torsades de pointes diseases used orally, the required supergraph of CAPS. treatment period - 8 - 12 weeks, with improvement of the dose gradually supergraph children older than 2 years of h. Indications for use supergraph Crohn's disease, ulcerative colitis in the acute Left Ventricular Outflow Track prevention of recurrence of Save Our Souls colitis, Crohn's disease, Mts colitis in the acute Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations Werner syndrome Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; supergraph d. Contraindications to the use of drugs: not installed. Saccharomyces bulardi supergraph . Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. 4 rdobu the supergraph In vitro fertilization here children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / supergraph per fraction;. Dosing and Administration of drugs: cap. Method of production of drugs: supergraph to 3 mg.